On telomeres long and short
Nathan Corbett, MSc; Martin Alda, MD Telomeres and their shortening have been studied in the con text of psychiatric disorders for about 10 years. A number of studies correlating telomere length (TL) with selected psycho pathologies have generated intriguing and largely consistent findings: many psychiatric disorders are associated with shorter leukocyte TL. Yet, this observation can be interpreted in alternative ways, and choosing among them remains diffi cult owing to missing key pieces of information.
Telomeres are, essentially, caps on ends of chromosomes. They consist of TTAGGG repeats that usually become shorter with each successive cell division. Their main roles are to pro tect chromosomes from a gradual loss of nucleotides in divid ing cells and to delineate DNA breakage from normal chro mosome ends. They also halt cell division through activation of DNA damage recognition systems in response to acute cel lular stress (e.g., radiation, oxidative stress), age (i.e., un capped short telomeres) and disruption of various telomere associated proteins (e.g., acquired or inherited mutations, cell signalling, toxins, drugs). 1 Telomere integrity is maintained by a specialized polymerase system and various associated structural and signalling proteins; accordingly, the telomere system provides cells with information about their individual history and physiologic context.
The enzyme telomerase can elongate telomeres, but does not compensate fully for the cell division-related shortening in so matic cells. Telomerase is not substantially active in most adult somatic cells, with the exception of the germ line cells, prolifer ating leukocytes and endometrium and has a limited function in stem cells. Telomerase activity declines precipitously during the teen years, while TL declines most rapidly in early de velop ment, with subsequent slower attrition through the rest of the life course. 1 Mean TL has been associated with 7 genetic loci that correspond with genes directly involved in telomere maintenance. 2 Thus, we infer that TL results from the differ ence between factors negatively impacting TL on one hand and telomerase activity on the other. In humans, TL is herit able both generally 3 and in specific cases of intergenerational telomere loss leading to genetic anticipation in a particular gen etic disease. 4 Telomere balance at any given time is a func tion of somatic growth rate, relevant genetics and epigenetics, age, environmental and physiologic context, psychological re sponse to the en vironment, 5 and physical or mental illness and/or its treatment, which define the rate of change in mean TL at any given time. These factors combined with the herit ability of TL "set points," which define early life (maximal) telomere length, determine somatic TL.
Populations vary dramatically in TL, even within regions, such as Europe, 6 that have traditionally been considered rela tively homogeneous and among people from different parts of the world. 7 Likewise, TL varies among specific tissues within the same organism. This complexity is a good reminder that the telomere system is not amenable to simplistic analysis.
Telomere length is typically measured in leukocytes and referred to as leukocyte TL (LTL). Most commonly, LTL is es timated via a ratio of telomeric repeat amplification to that of a known single copy gene in multiplex quantitative poly merase chain reaction (qPCR), 8 although other methods have better precision and celltype and chromosome specificity; 9 qPCR ratio does not describe the many telomeres of different lengths at every chromosome end in every cell or say any thing about variance between cells or cell populations in the given sample. Given that very short telomeres occur ran domly and with increasing probability at lower average TL, association between average TL and biomolecular reality is, at best, probabilistic. In addition, the normal variation in hu man average TL is substantial, necessitating large cohorts to achieve sufficient statistical power for inference testing. While current techniques are sufficient for highlevel descrip tive work, chromosome resolution, longitudinal "telomere velocity" studies will provide more useful information.
Among psychiatric disorders, LTL has been found to be significantly reduced in patients with bipolar disorder, psy chosis, major depression and anxiety disorders. Shorter telo meres are commonly thought to reflect -or result fromaccelerated aging processes. One proposed mechanism involves oxidative stress, negative impact of reactive oxygen species and impaired mitochondrial function. The same mechanisms may, for instance, play a role in the pathophysi ology of bipolar disorder and/or its progression, with recent results indicating that longterm lithium therapy leads to a detectable relative increase in LTL versus controls. 10 There is clearly much to learn in this regard, as lithium therapy has not been shown to modulate leukocyte telomerase function. colleagues 12 reported no difference between patients with depression and healthy controls. On the other hand, Sequeira and colleagues 13 found telomere shortening in the hippo cam pi, but not the dorsolateral prefrontal cortex, of indi viduals with depression. Also, agedependent TL reduction was present only in some brain regions. 13 By taking a different approach, Szebeni and colleagues 14 found TL shortening in white matter oligodendrocytes in major depression. In aggregate, brain cells have low levels of telomerase activity comparative to pro liferative tissues, such as bone marrow or mucosa, and dif ferent brain regions differ in cell type composition, having variable ratios of neurons and glial cells, which have distinct telomere dynamics due to categorically different rates of cell turnover. Shorter telo meres in stem cells may impair neuro genesis, 15 a mechanism hypothesized as relevant to the pathophysiology of mood disorders. Finally, a single study in Alzheimer disease found no correlation between LTL and brain TL, 16 though LTL has been associated with volumes of the relevant brain regions 17 and with disease status. The LTL in many psychiatric disorders appears to follow a dose-response pattern whereby more severe and more chronic conditions were associated with shorter telomeres, which has been demonstrated both in depression 5 and psy chosis. 18 This observation is consistent with the fact that these disorders and their progression are frequently associ ated with physical conditions that are also associated with shorter telomeres, such as metabolic syndrome or diabetes mellitus. Patients with these comorbid conditions are known to have poorer psychiatric outcomes. 19 In summary, we found a number of consistent and replicated findings, but their interpretation is not easy. A common view is that shorter telomeres reflect premature aging in psychiatric pa tients, and this aging is manifest in mitotically active cells. Telo mere shortening then would result from the same pathophysio logical processes (or allostatic factors involved in their etiology) affecting the body and the brain; for instance it could be a con sequence of metabolic and inflammatory changes associated with the progression of psychiatric disorders. But several im portant questions remain. First, the existing data do not allow us to determine if telomere shortening is present in all patients with major psychiatric disorders or whether it plays a role in only subtypes of disorders associated with inflammation and oxidative stress. 20 Also, we do not know if the TL and/or pro pensity for telomere shortening are associated with the predis position to major psychiatric disorders. To answer this ques tion, we may need a prospective analysis of TL in people at genetic risk for such disorders. Finally, it will be important to clarify the relevance of partial reversibility of pathological TL changes by treatment, for instance with lithium. 10 The effect of lithium is intriguing and appears to parallel its neuroprotective action. But similar to neuroprotective effects, it is not clear how essential it is for therapeutic response.
While telomeres present an intriguing window into the cel lular perspective on allostasis, the inherent complexity of this system warrants caution. Considerable resources have been expended in developing a robust literature in telomere science, largely thanks to the prominent role of telomeres in cancer biology, and it will be crucial to properly leverage this body of basic research to design and implement responsible research studies that clarify rather than confuse our understanding. Competing interests: None declared.
